{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T03:23:05Z","timestamp":1790220185185,"version":"4.1.0"},"reference-count":33,"publisher":"American Association for Cancer Research (AACR)","issue":"7","license":[{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"name":"US Postal Service Breast Cancer Stamp Fund"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180868"],"award-info":[{"award-number":["U10CA180868"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U10CA180822"],"award-info":[{"award-number":["U10CA180822"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UG1CA189867"],"award-info":[{"award-number":["UG1CA189867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["and U24CA196067"],"award-info":[{"award-number":["and U24CA196067"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U10CA180820 and U10CA180794"],"award-info":[{"award-number":["U10CA180820 and U10CA180794"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["5U24CA196172"],"award-info":[{"award-number":["5U24CA196172"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Late distant recurrence (DR) remains a persistent risk in hormone receptor\u2013positive (HR+) early breast cancer after completion of 5 years of endocrine therapy (ET). We developed and validated a multimodal artificial intelligence (AI) model to improve long-term risk stratification and to explore heterogeneity in benefit from extended letrozole therapy (ELT). The deep learning model integrating digitized hematoxylin and eosin whole-slide images with clinicopathologic variables was developed using 2,271 patients from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-42 trial with five-fold cross-validation and externally validated in 4,300 patients from the TAILORx trial who were disease-free at 5 years from the initial diagnosis. Prognostic performance was evaluated using hazard ratios (HR) and absolute risk differences. Exploratory analyses assessed ELT benefit across model-defined risk groups. In NSABP B-42, the model stratified patients into groups with markedly different outcomes, with a 10-year absolute DR risk difference of 7.95% between high- and low-risk groups [HR, 5.71; 95% confidence interval (CI), 3.5\u20139.317; P &amp;lt; 0.001]. High-risk patients derived greater absolute benefit from ELT (4.09%) than low-risk patients (0.49%). External validation in the independent TAILORx cohort confirmed prognostic performance, with MI Clarity multimodal\u2013multitask identifying patients with significantly different late DR outcomes (HR, 1.893; 95% CI, 1.413\u20132.534; P &amp;lt; 0.001). This multimodal AI approach using routine pathology and clinical data enables robust and generalizable stratification of late DR risk in HR+ breast cancer. This scalable strategy may complement existing genomic assays and support more individualized decisions about extended ET.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>Late DR is a major cause of death in HR+ breast cancer, and deciding who needs longer hormone therapy is challenging. Current genomic tests are useful but have limitations. This study shows that an AI model using pathology and clinical data identifies patients at high or low risk of late recurrence. High-risk patients may benefit more from extended hormone therapy, offering an accessible way to guide treatment decisions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/2767-9764.crc-26-0362","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:41:21Z","timestamp":1784317281000},"page":"1825-1835","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Development and Validation of a Multimodal\u2013Multitask Deep Learning Approach for Estimating Late Distant Recurrence Risk in HR-Positive Early Breast Cancer"],"prefix":"10.1158","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9476-2553","authenticated-orcid":false,"given":"Eleftherios P.","family":"Mamounas","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05e2f9085","id-type":"ROR","asserted-by":"publisher"}],"name":"NSABP Foundation 1 , NRG Oncology, Pittsburgh, Pennsylvania."},{"name":"2AdventHealth Cancer Institute, Orlando, Florida."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-2322-5258","authenticated-orcid":false,"given":"Ming","family":"Chen","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9031-2010","authenticated-orcid":false,"given":"Joseph A.","family":"Sparano","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/04a9tmd77","id-type":"ROR","asserted-by":"publisher"}],"name":"Icahn School of Medicine at Mount Sinai 4 , Tisch Cancer Institute, New York, New York."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6062-1998","authenticated-orcid":false,"given":"Md Ashequr","family":"Rahman","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2352-8647","authenticated-orcid":false,"given":"Yating","family":"Cheng","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4079-5576","authenticated-orcid":false,"given":"Victoria","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 5 ECOG-ACRIN Biostatistical Center, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5724-4917","authenticated-orcid":false,"given":"Robert J.","family":"Gray","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/02jzgtq86","id-type":"ROR","asserted-by":"publisher"}],"name":"Dana-Farber Cancer Institute 5 ECOG-ACRIN Biostatistical Center, , Boston, Massachusetts."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6179-6407","authenticated-orcid":false,"given":"Priya","family":"Rastogi","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05e2f9085","id-type":"ROR","asserted-by":"publisher"}],"name":"NSABP Foundation 1 , NRG Oncology, Pittsburgh, Pennsylvania."},{"name":"6University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1302-9039","authenticated-orcid":false,"given":"Eghbal","family":"Amidi","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-5702","authenticated-orcid":false,"suffix":"Jr","given":"Charles E.","family":"Geyer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05e2f9085","id-type":"ROR","asserted-by":"publisher"}],"name":"NSABP Foundation 1 , NRG Oncology, Pittsburgh, Pennsylvania."},{"name":"6University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5025-090X","authenticated-orcid":false,"given":"Tommy","family":"Boucher","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7221-4647","authenticated-orcid":false,"given":"Tanner J.","family":"Freeman","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05e2f9085","id-type":"ROR","asserted-by":"publisher"}],"name":"NSABP Foundation 1 , NRG Oncology, Pittsburgh, Pennsylvania."},{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 7 , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3418-339X","authenticated-orcid":false,"given":"Mohammadreza","family":"Ramzanpour","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9254-1247","authenticated-orcid":false,"given":"Mukund","family":"Varma","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0993-8094","authenticated-orcid":false,"given":"Hassan","family":"Ghani","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8806-3185","authenticated-orcid":false,"given":"Caleb","family":"Cheng","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1016-6042","authenticated-orcid":false,"given":"Casey","family":"Bales","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1685-8568","authenticated-orcid":false,"given":"Jennifer R.","family":"Ribeiro","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1798-8054","authenticated-orcid":false,"given":"Hanna","family":"Bandos","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an3r305","id-type":"ROR","asserted-by":"publisher"}],"name":"University of Pittsburgh 8 NRG Oncology Statistical and Data Management Center, Department of Biostatistics and Health Data Science, , Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2778-4293","authenticated-orcid":false,"given":"Nicolas","family":"Stransky","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9170-5899","authenticated-orcid":false,"given":"Mark R.","family":"Miglarese","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-2513","authenticated-orcid":false,"given":"Matthew","family":"Oberley","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9531-0970","authenticated-orcid":false,"given":"David","family":"Spetzler","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9667-156X","authenticated-orcid":false,"given":"Milan","family":"Radovich","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0297-0775","authenticated-orcid":false,"given":"George W.","family":"Sledge","sequence":"additional","affiliation":[{"name":"3Caris Life Sciences, Phoenix, Arizona."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7156-1110","authenticated-orcid":false,"given":"Norman","family":"Wolmark","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05e2f9085","id-type":"ROR","asserted-by":"publisher"}],"name":"NSABP Foundation 1 , NRG Oncology, Pittsburgh, Pennsylvania."},{"name":"6University of Pittsburgh School of Medicine, UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2026,7,31]]},"reference":[{"key":"2026073105125999100_bib1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"2026073105125999100_bib2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1056\/NEJMoa1701830","article-title":"20-year risks of breast-cancer recurrence after stopping endocrine therapy at 5 years","volume":"377","author":"Pan","year":"2017","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib3","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1056\/nejmoa2104162","article-title":"Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer","volume":"385","author":"Gnant","year":"2021","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(18)30621-1","article-title":"Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology\/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"20","author":"Mamounas","year":"2019","journal-title":"Lancet Oncol"},{"key":"2026073105125999100_bib5","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/S0140-6736(12)61963-1","article-title":"Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial","volume":"381","author":"Davies","year":"2013","journal-title":"Lancet"},{"key":"2026073105125999100_bib6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJMoa1604700","article-title":"Extending aromatase-inhibitor adjuvant therapy to 10 years","volume":"375","author":"Goss","year":"2016","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib7","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1200\/JCO.2007.14.0228","article-title":"Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast and Bowel Project B-33 trial","volume":"26","author":"Mamounas","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026073105125999100_bib8","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/jnci\/djad078","article-title":"Ten-year update: NRG Oncology\/National Surgical Adjuvant Breast and Bowel Project B-42 randomized trial: extended letrozole therapy in early-stage breast cancer","volume":"115","author":"Mamounas","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"2026073105125999100_bib9","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1200\/JCO.2017.76.4258","article-title":"Integration of clinical variables for the prediction of late distant recurrence in patients with estrogen receptor-positive breast cancer treated with 5 years of endocrine therapy: CTS5","volume":"36","author":"Dowsett","year":"2018","journal-title":"J Clin Oncol"},{"key":"2026073105125999100_bib10","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1001\/jamaoncol.2018.2574","article-title":"Association of circulating tumor cells with late recurrence of estrogen receptor-positive breast cancer: a secondary analysis of a randomized clinical trial","volume":"4","author":"Sparano","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026073105125999100_bib11","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1200\/JCO.22.00908","article-title":"Circulating tumor DNA and late recurrence in high-risk hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer","volume":"40","author":"Lipsyc-Sharf","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026073105125999100_bib12","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/s1470-2045(13)70387-5","article-title":"Prediction of late distant recurrence in patients with oestrogen-receptor-positive breast cancer: a prospective comparison of the breast-cancer index (BCI) assay, 21-gene recurrence score, and IHC4 in the TransATAC study population","volume":"14","author":"Sgroi","year":"2013","journal-title":"Lancet Oncol"},{"key":"2026073105125999100_bib13","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1158\/1078-0432.CCR-23-1977","article-title":"Breast cancer index and prediction of extended aromatase inhibitor therapy benefit in hormone receptor-positive breast cancer from the NRG Oncology\/NSABP B-42 trial","volume":"30","author":"Mamounas","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026073105125999100_bib14","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1200\/JCO.22.00069","article-title":"Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update","volume":"40","author":"Andre","year":"2022","journal-title":"J Clin Oncol"},{"key":"2026073105125999100_bib15","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-gene signature as an aid to treatment decisions in early-stage breast cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib16","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/s1470-2045(21)00007-3","article-title":"70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age","volume":"22","author":"Piccart","year":"2021","journal-title":"Lancet Oncol"},{"key":"2026073105125999100_bib17","doi-asserted-by":"publisher","first-page":"3561","DOI":"10.1200\/JCO.23.01995","article-title":"Utility of the 70-gene MammaPrint assay for prediction of benefit from extended letrozole therapy in the NRG Oncology\/NSABP B-42 trial","volume":"42","author":"Rastogi","year":"2024","journal-title":"J Clin Oncol"},{"key":"2026073105125999100_bib18","doi-asserted-by":"publisher","first-page":"e2447530","DOI":"10.1001\/jamanetworkopen.2024.47530","article-title":"Selection of patients with early-stage breast cancer for extended endocrine therapy: a secondary analysis of the IDEAL randomized clinical trial","volume":"7","author":"van\u2019t Veer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2026073105125999100_bib19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41746-022-00613-w","article-title":"Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials","volume":"5","author":"Esteva","year":"2022","journal-title":"NPJ Digital Med"},{"key":"2026073105125999100_bib20","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/S2589-7500(23)00208-X","article-title":"End-to-end prognostication in colorectal cancer by deep learning: a retrospective, multicentre study","volume":"6","author":"Jiang","year":"2024","journal-title":"Lancet Digital Health"},{"key":"2026073105125999100_bib21","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1038\/s41467-025-57283-x","article-title":"Multimodal histopathologic models stratify hormone receptor-positive early breast cancer","volume":"16","author":"Boehm","year":"2025","journal-title":"Nat Commun"},{"key":"2026073105125999100_bib22","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1038\/s41467-025-60824-z","article-title":"Deep learning assessment of metastatic relapse risk from digitized breast cancer histological slides","volume":"16","author":"Garberis","year":"2025","journal-title":"Nat Commun"},{"key":"2026073105125999100_bib23","first-page":"254","article-title":"Joint multi-task learning improves weakly-supervised biomarker prediction in computational pathology","volume-title":"Linguraru MG, Dou Q, Feragen A, Giannarou S, Glocker B, Lekadir K, et al, editors. Medical Image Computing and Computer-Assisted Intervention \u2013 MICCAI 2024. Lecture notes in computer science","author":"El Nahhas","year":"2024"},{"key":"2026073105125999100_bib24","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/CCI.18.00157","article-title":"HistoQC: an open-source quality control tool for digital pathology slides","volume":"3","author":"Janowczyk","year":"2019","journal-title":"JCO Clin Cancer Inform"},{"key":"2026073105125999100_bib26","doi-asserted-by":"publisher","first-page":"102559","DOI":"10.1016\/j.media.2022.102559","article-title":"Transformer-based unsupervised contrastive learning for histopathological image classification","volume":"81","author":"Wang","year":"2022","journal-title":"Med Image Anal"},{"key":"2026073105125999100_bib27","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1038\/s41591-024-03141-0","article-title":"A foundation model for clinical-grade computational pathology and rare cancers detection","volume":"30","author":"Vorontsov","year":"2024","journal-title":"Nat Med"},{"key":"2026073105125999100_bib28","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41591-024-02856-4","article-title":"A visual-language foundation model for computational pathology","volume":"30","author":"Lu","year":"2024","journal-title":"Nat Med"},{"key":"2026073105125999100_bib29","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41586-024-07894-z","article-title":"A pathology foundation model for cancer diagnosis and prognosis prediction","volume":"634","author":"Wang","year":"2024","journal-title":"Nature"},{"key":"2026073105125999100_bib30","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1056\/nejmoa2305488","article-title":"Ribociclib plus endocrine therapy in early breast cancer","volume":"390","author":"Slamon","year":"2024","journal-title":"N Engl J Med"},{"key":"2026073105125999100_bib31","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1470-2045(22)00694-5","article-title":"Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial","volume":"24","author":"Johnston","year":"2023","journal-title":"Lancet Oncol"},{"key":"2026073105125999100_bib32","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s40291-020-00482-7","article-title":"Oncotype DX Breast Recurrence Score\u00ae: a review of its use in early-stage breast cancer","volume":"24","author":"Syed","year":"2020","journal-title":"Mol Diagn Ther"},{"key":"2026073105125999100_bib33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1158\/1078-0432.CCR-20-2737","article-title":"Breast cancer index predicts extended endocrine benefit to individualize selection of patients with HR+ early-stage breast cancer for 10 years of endocrine therapy","volume":"27","author":"Noordhoek","year":"2021","journal-title":"Clin Cancer Res"}],"container-title":["Cancer Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/doi\/10.1158\/2767-9764.CRC-26-0362\/3813709\/crc-26-0362.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/7\/1825\/3818504\/crc-26-0362.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article-pdf\/6\/7\/1825\/3818504\/crc-26-0362.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T09:13:11Z","timestamp":1785489191000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerrescommun\/article\/6\/7\/1825\/787228\/Development-and-Validation-of-a-Multimodal"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1158\/2767-9764.crc-26-0362","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/2767-9764.33129762","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129750","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129720","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129759","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129747","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129717","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129705","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129711","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129765","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129735","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129723","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129729","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129696","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129753","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129741","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129726","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129714","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129738","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129699","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129744","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129732","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129702","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129768","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129756","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/2767-9764.33129708","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/2767-9764.c.8627529","asserted-by":"object"}]},"ISSN":["2767-9764"],"issn-type":[{"value":"2767-9764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}